Challenges of NK cell-based immunotherapy in the new era

被引：0
作者：
Fang Fang
Weihua Xiao
Zhigang Tian
机构：
[1] University of Science and Technology of China,Institute of Immunology and the CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Signaling Network, School of Life Sciences and Medical Center
[2] Hefei National Laboratory for Physical Sciences at Microscale,undefined
来源：
Frontiers of Medicine | 2018年 / 12卷
关键词：
natural killer cells; immunotherapy; adoptive transfer; genetic modification; immune checkpoint inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Natural killer cells (NKs) have a great potential for cancer immunotherapy because they can rapidly and directly kill transformed cells in the absence of antigen presensitization. Various cellular sources, including peripheral blood mononuclear cells (PBMCs), stem cells, and NK cell lines, have been used for producing NK cells. In particular, NK cells that expanded from allogeneic PBMCs exhibit better efficacy than those that did not. However, considering the safety, activities, and reliability of the cell products, researchers must develop an optimal protocol for producing NK cells from PBMCs in the manufacture setting and clinical therapeutic regimen. In this review, the challenges on NK cell-based therapeutic approaches and clinical outcomes are discussed.
引用
收藏
页码：440 / 450
页数：10
相关论文
共 1216 条
[1]  
Herberman RB(1975)Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity Int J Cancer 16 216-229
[2]  
Nunn ME(1975)“Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell Eur J Immuno 5 117-121
[3]  
Lavrin DH(2017)Deciphering the killer-cell immunoglobulin-like receptor system at super-resolution for natural killer an. T-cell biology Immunolog 150 248-264
[4]  
Kiessling R(2015)Balancing natural killer cell activation through paired receptors Nat Rev Immunol 15 243-254
[5]  
Klein E(2015)Natural killer cell immunomodulation: targeting activating, inhibitory, and co-stimulatory receptor signaling for cancer immunotherapy Front Immunol 6 601-330
[6]  
Pross H(2017)NK cell education via nonclassical MHC and non- MHC ligands Cell Mol Immuno 14 321-510
[7]  
Wigzell H(2008)Functions of natural killer cells Nat Immuno 9 503-11
[8]  
Béziat V(2017)Uncompromised NKcell activation is essential for virus-specifi. CTL activity during acute influenza virus infection Cell Mol Immuno 14 1-657
[9]  
Hilton HG(2011)NK cell development, homeostasis and function: parallels wit. CD8+ T cells Nat Rev Immuno 11 645-638
[10]  
Norman PJ(2017)Natural killer T cells in cancer immunotherapy Front Immunol 8 1178-491
12345678910